Benchmark (BMK) FY20 results analyst presentation
This video can be seen at: https://www.piworld.co.uk/2020/12/14/benchmark-bmk-fy20-results-analyst-presentation/ Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts. A transformational year, completing the restructuring, wit
Episode 323 of the PIWORLD Investor Podcasts podcast, hosted by www.piworld.co.uk, titled "Benchmark (BMK) FY20 results analyst presentation" was published on December 14, 2020 and runs 31 minutes.
December 14, 2020 ·31m · PIWORLD Investor Podcasts
Summary
This video can be seen at: https://www.piworld.co.uk/2020/12/14/benchmark-bmk-fy20-results-analyst-presentation/ Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts. A transformational year, completing the restructuring, with good growth opportunities and long-term growth drivers. Trond Williksen, CFOIntroduction – 00:20Overview – 00:49Benchmarks objectives - 04:21 Septima Maguire, CFOFinancials – 05:49 Trond Williksen, CFOStrategy – 18:23Outlook & guidance – 28:08 Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.
Episode Description
Trond Williksen, CEO & Spetima Maguire, CFO present FY20 results to analysts. A transformational year, completing the restructuring, with good growth opportunities and long-term growth drivers.
Trond Williksen, CFO
Introduction – 00:20
Overview – 00:49
Benchmarks objectives - 04:21
Septima Maguire, CFO
Financials – 05:49
Trond Williksen, CFO
Strategy – 18:23
Outlook & guidance – 28:08
Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.